Sepsis
1,615
195
226
792
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
85 trials with published results (5%)
Research Maturity
792 completed trials (49% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.8%
61 terminated out of 1615 trials
92.8%
+6.3% vs benchmark
12%
187 trials in Phase 3/4
11%
85 of 792 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 792 completed trials
Clinical Trials (1615)
CLARITHROMYCIN TO PREVENT SECONDARY INFECTIONS IN PATIENTS WITH SEPSIS FOLLOWING LOWER RESPIRATORY TRACT INFECTIONS: THE CLASSIFY TRIAL
THE ROLE OF PANCREATIC STONE PROTEIN (PSP) AND PSP-GUIDED EARLY MEROPENEM TREATMENT TO MITIGATE SEPSIS RISK AT THE EMERGENCY DEPARTMENT: THE PROMISE DOUBLE BLIND, PHASE III, RANDOMIZED CONTROLLED CLINICAL TRIAL
Effect of Adjunctive Ursodeoxycholic Acid on Oxidative Stress, Inflammation, and Organ Dysfunction in Adults With Sepsis
Study of Obese Patients Comparing Two Vancomycin Loading Dose Regimens
High-Sensitivity Troponin T Kinetics and 30-Day Outcomes After Major Abdominal Surgery (TROP-MAS)
Immunoinflammatory Regulation of Esketamine in Septic Patients
Peripheral Perfusion Index Trajectory to Predict 28-Day Mortality in Patients With Sepsis in the Intensive Care Unit
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
Implementation of a Sepsis Chart and Its Effects on Mortality Rate in Indonesian Primary Referral Hospitals
NAI Plus Standard of Care Compared With Placebo Plus Standard of Care in Critically Ill Adults With Sepsis
Molecular-based Optimization of Pathogen Identification in Sepsis Patients in the Indonesian National Referral Hospital
Myeloid Bias in the Bone Marrow of Septic Patients and Its Correlation With Disease Severity and Prognosis: A Single-Center, Prospective Cohort Study
FMT for 90-Day Outcome of Clinical Use in ICU Sepsis
Assessing Immune Dysfunction in Sepsis
Immune Responses to Dengue and Sepsis
Clinical Efficacy of Ulinastatin for Treatment of Sepsis With Systemic Inflammatory Response Syndrome
A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy
Sepsis Associated Liver Injury in Pediatric Sepsis at Assiut University Children's Hospital - 2026
Use of Procalcitonin, a Blood Test to Guide Antibiotic Therapy for Sepsis in Adults
Nucleosome Monitoring Relevance for Outcome Prediction in Critically Ill Patients